Navigation Links
CIGNA Group Insurance Shows Consumers 'There's More to Life' Through a New Consumer Education Toolkit
Date:9/4/2007

Online life insurance calculator available in conjunction with Life

Insurance Awareness Month

PHILADELPHIA, Sept. 4, 2007 /PRNewswire-FirstCall/ -- According to LIMRA International, parents in the United States find buying life insurance complex and confusing -- half don't know how much to buy and 39 percent worry about making the wrong decision (1). To help consumers learn more about life insurance, CIGNA Group Insurance has created a new online consumer education toolkit, available at http://www.cigna.com/liam.

The toolkit, launched at the start of Life Insurance Awareness Month, provides consumers with information and resources, including a life insurance calculator that helps answer a common consumer question -- "how much life insurance do I need?"

"Life insurance undoubtedly provides financial security for loved ones after a person dies. It is an essential part of an individual's financial plan and is often available at an affordable cost as part of his or her employee benefits package," said Jim Jacobsen, vice president of product for CIGNA Group Insurance. "Beyond these important aspects, CIGNA recognizes there is more to life. CIGNA offers many value-added benefits along with our life insurance policies to help people maintain their health, well-being and security throughout their lifetimes."

Within the new online consumer education toolkit, individuals can learn more about several added benefits available to them as life insurance policyholders, including:

-- CIGNA Life Assistance(SM) offers support, counseling and resources to

help individuals cope with a wide range of issues, from parenting

challenges to financial or legal matters. All services are confidential

and can be accessed 24 hours a day, 365 days a year.

-- CIGNA's Healthy Rewards(R) discount program, offered in conjunction

with CIGNA Li
'/>"/>

SOURCE CIGNA Group Insurance
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CIGNA HealthCare Teams With HopeLab to Help Blast Teen Cancer
2. No link between blood groups and prostate cancer
3. Consumer group seeks Sibutramine ban
4. Suicide risk high in 12-17 Age Group
5. Religious groups overcome objections to cervical cancer vaccines
6. Wockhardt Group Plans Hospital In Delhi By End-2007
7. Group Suicides On The Rise In Japan
8. Yogic Moments: Age Old Yoga, Benefits All Age Groups
9. Group Jogging More Beneficial To Health Than Solo Jogging
10. Plastic Surgery Is Primetime among Ethnic Groups
11. Study Finds Online Support Groups Emotionally Benefit Women Suffering From
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Dr. Stephen Cohen Hired As New CEO, ATLANTA,...r Group,(GMCG) announced today that MELCO Investme...ment fund, has signed on as a key partner with a,s...the investment, GMCG has,also appointed Dr. Stephe...,surgeons, as its new CEO., (Photo: http://www.n...
(Date:7/23/2008)...d and Medicare Rules Highlighted; a Focus on Preve...tions, LANSING, Mich., July 23 /PRNewswire/ -- Th...&PSI), a national leader in clinical risk manageme... care institutions and,providers, today announced ... conference., The conference will take place Sept...
(Date:7/23/2008)... Michigan Takes Top Honors as the #1 Healthiest Ci...PRNewswire-USNewswire/ -- AARP The Magazine, the,d...largest-circulation,magazine with more than 34 mil...st cities to live and retire in with Ann Arbor, MI...go, ND taking the top five rankings.,Featured in t...
(Date:7/23/2008)...a., July 23 /PRNewswire-USNewswire/ -- The HealthC...m ) today announced that Dr. Fran Cogen,MD, direc...am at Children,s,National Medical Center, will pro...om, a site offering connections to a community of ...priate consultation by a dietician, social,worker,...
Breaking Medicine News(10 mins):Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5Health News:Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Network's Teen Diabetes Site 2
...nza can be slowed by immunizing chickens. The dise...vaccine has been developed for protecting chickens...ndrea Gambotto of the University of Pittsburgh. ... advantageous way of stopping the spread of the di...
...ter of the Indian state of Kerala underwent a surg...ng his hip after a fall. // He was visiting Switze..., with the object of promoting his state as an inv...overing well after the surgery, even though he wil...
...ission (NHRC) has called for a report with regard ...dneys and has issued the Chief Secretary and the D...unjab with a notice. // As many as 300 laborers i...eys since the year 2001, and about 25 of them are ...
...e US in 2005 from the fatal arrhythmias through de...As many as 1,70,000 people in North America receiv...o found this to be uncomfortable, unnecessary, and...loped recently to find out which of the patients a...
Other Medicine News:
(Date:7/21/2008)...iev, M.D., president of SPRI,Clinical Trials, will...Wall,Street Unplugged: The Trout Group Investor Se...nference will be held on Wednesday, July 30, at Mi.... The event is targeted to CEOs,and CFOs at privat...gain,better insight into Wall Street and maximize ...
(Date:7/21/2008)...S (Simvastatin and Ezetimibe in,Aortic Stenosis) s...lesterol lowering with the combination of simvasta...atients with aortic stenosis., Aortic stenosis (w... in,the heart) is a relatively common disease amon...ted, it can progress to death from heart failure o...
(Date:7/21/2008)...S Study" issued on 21 Jul 2008,07:00 GMT, by Prof ... Head,of Steering Committee over PR Newswire, we a... that the following information has been added to ...ess and URL for webcast:, Satellite: European Sa...l 2 DL: 11152.700 V symbol rate 5.632 FEC 3/4, ...
(Date:7/21/2008)...s identify risk in patients, including non-diab...y, BIRMINGHAM, Ala., July 21 /- Usin...chers have identified a link between,adiponectin a...d help,physicians trying to pinpoint the most effe...treatments in at-risk patients., The association ...
Breaking Medicine Technology:Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 2/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 3VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Doctors Slow to Embrace Electronic Medical Records 22245 1Doctors Slow to Embrace Electronic Medical Records 22245 2Doctors Slow to Embrace Electronic Medical Records 22245 3Psych Central Selected by TIME Magazine as Top 50 Web Site in 2008 for Its Top Mental Health Content and Social Media Platform 22241 1Psych Central Selected by TIME Magazine as Top 50 Web Site in 2008 for Its Top Mental Health Content and Social Media Platform 22241 2Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 1Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 2Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 3Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 4Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 5AAHSA Statement on Nursing Home Rating System 22237 1AAHSA Statement on Nursing Home Rating System 22237 2
... - Abraxis BioScience,Inc. (NASDAQ:ABBI), an inte...d first-time data from a pre-clinical study,evalua...mycin,(ABI-009), an albumin-bound mTOR kinase inhi... Research (AACR) Annual Meeting held,April 14-18, ...,study demonstrated that nab-rapamycin was well-to...
...r 19, 2007 - Amgen,(NASDAQ: AMGN) today announced ...le-blind, placebo-controlled, multicenter Phase 3,...iously untreated,patients with extensive-stage sma...aining chemotherapy. The study demonstrated,no sta... (overall,survival Aranesp compared to placebo Haz...
Other Medicine Technology:Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 2Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 3Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7
This stain is a classical hematology stain that requires a longer staining time but produces a very dense coloration. It is used in the staining of peripheral blood smears and bone marrows. The resul
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast.
Albumin reagent is used for the quantitative determination of albumin concentration in human serum.
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum.
Medicine Products: